Head and neck atopic dermatitis and malassezia-furfur-specific IgE antibodies

O Bayrou1, C Pecquet, A Flahault

  • 1Centre d'allergologie, INSERM Unité 444, Hôpital Tenon, Paris, France. olivier.bayrou@tnn.ap-hop-paris.fr

Dermatology (Basel, Switzerland)
|August 10, 2005
PubMed
Abstract

Insights

Specific IgE antibodies to Malassezia furfur (yeast) are a reliable marker for head and neck atopic dermatitis (HNAD). Higher antibody levels correlate with increased disease severity in HNAD patients.

Area of Science:

  • Dermatology
  • Immunology
  • Allergology

Background:

  • Head and neck atopic dermatitis (HNAD) is a distinct clinical condition.
  • Malassezia furfur, a yeast, is implicated as a key allergen in HNAD.

Purpose of the Study:

  • To quantify IgE antibodies targeting Malassezia furfur.
  • To investigate the relationship between these antibodies and HNAD severity.

Main Methods:

  • Assayed IgE anti-M. furfur antibodies in 106 HNAD patients.
  • Included control groups: non-HNAD, non-atopic dermatitis, and seborrheic dermatitis.

Main Results:

  • A strong correlation was found between IgE anti-M. furfur levels and clinical severity.
  • Total IgE also correlated with severity, though less strongly.
  • Total IgE levels were higher in male HNAD patients.

Conclusions:

  • IgE antibodies to Malassezia furfur serve as a specific and effective biomarker for HNAD.
  • Elevated IgE M. furfur levels are significantly associated with disease severity.